FDA approves first freeze-dried plasma product for U.S. use
The FDA has licensed Ezplaz Freeze Dried Plasma (FDP), marking the first freeze-dried plasma product cleared for use in the United States.
The product is intended for adult patients who need plasma when other plasma products are unavailable, such as in combat zones, disaster sites, rural or other austere settings. It can be stored at room temperature, remains stable through temperature changes, and can be reconstituted quickly, offering faster access compared with conventional frozen plasma that requires thawing.
Ezplaz is derived from a single unit of fresh frozen plasma and is offered in Group AB and Group A low-titer anti-B blood types to reduce risk when a patient’s blood type is unknown. It is packaged in a plastic bag rather than a glass bottle, lowering breakage risk during transport.
This writeup was produced by pharmadog from original reporting by fda press.
Original headline: “FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.”
read at fda press ↗
comments(0)
5-min edit window · permanent after that